-
1
المؤلفون: Anton Hagenbeek, Angelika Bischof Delaloye, Jens Kuhlmann, Cristian Antonescu, Thomas Louton
المساهمون: Cancer Center Amsterdam, Clinical Haematology
المصدر: Journal of nuclear medicine, 50(11), 1837-1843. Society of Nuclear Medicine Inc.
مصطلحات موضوعية: Adult, Male, Internationality, medicine.medical_treatment, Follicular lymphoma, Radiation Dosage, medicine, Humans, Dosimetry, Radiology, Nuclear Medicine and imaging, Radiometry, Lymphoma, Follicular, Aged, Neoplasm Staging, Chemotherapy, business.industry, Antibodies, Monoclonal, Environmental Exposure, Middle Aged, Radioimmunotherapy, medicine.disease, Treatment Outcome, medicine.anatomical_structure, Absorbed dose, Toxicity, Female, Rituximab, Bone marrow, Nuclear medicine, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b46343eed4d034f57ced5ee5070274f5
https://pure.amc.nl/en/publications/dosimetry-of-90yibritumomab-tiuxetan-as-consolidation-of-first-remission-in-advancedstage-follicular-lymphoma-results-from-the-international-phase-3-firstline-indolent-trial(ff0df5f6-ba3c-46f4-939e-8a30540f5e2b).html